Background and Aim: Patients with gastroesophageal reflux disease (GERD) have decreased health-related quality of life (HRQL). The quality of life in patients with laryngopharyngeal reflux (LPR) symptoms is also significantly impaired. However, the impact of LPR symptoms on HRQL in GERD patients has not been studied. Methods: A nationwide, random-sample, and face-to-face survey of 300 Korean patients with GERD was conducted from January to March 2013. Gastroesophageal reflux symptoms were assessed using the Rome III questionnaire, LPR symptoms using the reflux symptom index, and HRQL using the EuroQol five dimensions (EQ-5D) questionnaire. A structured questionnaire on patient satisfaction, sickness-related absences, and healthrelated work productivity was also used. Results: Among the 300 patients with GERD, 150 had LPR symptoms. The mean EQ-5D index was lower in patients with GERD and LPR symptoms than in those without LPR (0.88 vs 0.91, P = 0.002). A linear regression model showed that the severity of LPR symptoms was related to decreased HRQL and was independent of age, marital status, body mass index, or household income. The overall satisfaction rate regarding treatment was lower in patients with GERD and LPR (40.0% vs 69.1%, P = 0.040). GERD patients with LPR symptoms reported greater sickness-related absent hours per week (0.36 vs 0.02 h, P = 0.016) and greater percentages of overall work impairment than those without LPR (31.1% vs 20.8%, P < 0.001). Conclusions: Gastroesophageal reflux disease patients with LPR symptoms have a poorer HRQL, a lower satisfaction rate, and a greater disease burden than those without LPR.
Introduction
Gastroesophageal reflux disease (GERD) is one of the most common problems affecting the gastrointestinal tract. It is characterized by heartburn and acid regurgitation. The prevalence of GERD is growing, although it has a relatively lower prevalence in Asia than in Western countries. 1, 2 Several studies have assessed the impact of GERD on health-related quality of life (HRQL), showing a significant impairment of HRQL in patients with GERD compared to the general population. 3, 4 The increasing frequency and severity of reflux symptoms has a negative impact on wellbeing, and alleviating GERD symptoms is associated with improved HRQL. [3] [4] [5] [6] When gastric refluxate reaches the larynx or pharynx, it is referred to as laryngopharyngeal reflux (LPR). Although the exact prevalence of LPR is not known, because of the lack of a clear diagnostic test, the estimated prevalence of laryngeal disorders among GERD patients has been reported to be 10.4%. 7 Patients with LPR often present with laryngeal symptoms such as globus sensation, hoarseness, throat clearing, and chronic cough. 8, 9 These symptoms are known to respond more slowly to treatment than esophageal symptoms because of their chronic intermittent nature, requiring a longer period of treatment than esophageal symptoms alone. 10, 11 The quality of life in patients with LPR symptoms is also significantly impaired. 9 The persistence of LPR symptoms may result in substantial medical and social costs, such as work absenteeism. However, studies evaluating the impact of LPR symptoms on HRQL in GERD patients are limited. Furthermore, there have been no studies on the difference in disease burden between GERD patients with and without LPR symptoms. In our present study, we compared HRQL, patient satisfaction, and disease burden in GERD patients, according to the presence of LPR symptoms.
Methods
Study population. A nationwide survey was conducted from January to March 2013. The region of residence for survey participants consisted of seven first-level cities in Korea, including one special city (Seoul) and six metropolitan cities (Busan, Daegu, Daejeon, Gwangju, Incheon, and Ulsan). The population of these first-level cities was 46.1% of the total population of the country, according to the 2010 census by the Korean statistical information service. The sampling frame was created based on a previous nationwide, population-based telephone survey in terms of the distribution of age, sex, and region of residence by quota sampling. 12 The selection of participants consisted of two stages. Initial screening was performed using a computer-aided web interview (CAWI) system. From the Master Sample panel, which is a pool of prospective respondents who have signed up to voluntarily take part in surveys, subjects were invited by email to participate in the study. Among the 130 380 Master Sample panelists who live in seven first-level cities and are aged 20 years or older, 30 821 opened the email and 17 461 responded to CAWI. Of the respondents, 1914 (11.0%) reported having GERD. After quota sampling, 899 patients with GERD were eligible for this study. Of these, 492 patients were excluded because of their refusal to participate in a face-to-face interview (n = 390) or having an incomplete response to the CAWI questionnaire (n = 102). Ultimately, 150 patients with GERD and 150 patients with GERD and LPR symptoms were selected according to the order in which they completed CAWI, and they were interviewed face-to-face by one of the 55 experienced interviewers from Hankook Research Ltd., Korea (Fig. 1 ). Education and training programs were provided to maintain and standardize the quality of this survey.
Definition and questionnaires. Gastroesophageal reflux disease was defined as any troublesome heartburn and/or acid regurgitation at least once a week over the past 3 months. Gastroesophageal reflux symptoms were assessed by the Rome III-K questionnaire, which has been validated in Korea. 13 LPR symptoms were evaluated by the reflux symptom index (RSI), which is a validated clinical tool.
14,15 RSI consists of nine items, and the scale for each item ranges from 0 (no problem) to 5 (severe problem). LPR symptoms were considered to be positive when the RSI score was 14 or more.
Quality of life was assessed using the Korean version of the EuroQol five dimensions (EQ-5D) questionnaire. The EQ-5D questionnaire consists of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels: no problems (level 1), some problems (level 2), and extreme problems (level 3). The EQ-5D index was calculated using a Korean validation set; the values of the EQ-5D index range from 0 to 1, where 1 represents a state of being in full health. 16 Satisfaction with the treatment was assessed using a 5-point Likert scale for four categories: overall satisfaction, physician (concern over symptoms, assurance, professional knowledge, and explanation), cost, and treatment outcome. The scores range from 1 to 5, with higher scores representing greater satisfaction.
Health-related work productivity was measured using the Work Productivity and Activity Impairment questionnaire. 17 This validated questionnaire assesses absences from work, impairment at work, work productivity, and activity impairment with a 7-day recall period. Activity impairment outcomes are presented as percentages, with higher percentages indicating greater impairment and less productivity.
Statistical analysis. Differences between clinical characteristics were determined using the chi-squared test, Fisher's exact test, Student's t-test, or the Mann-Whitney U-test, as appropriate. The associations between clinical and socioeconomic characteristics and the HRQL of GERD patients were assessed using a linear regression model with a stepwise selection method. All statistical analyses were performed using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA), and P values <0.05 were considered statistically significant.
Results
The baseline characteristics of the study patients are summarized in Table 1 . Among 300 patients with GERD, the mean age was 43.5 AE 12.6 years, and 141 patients (47.0%) were male. Regarding typical reflux symptoms, 100 patients (33.3%) complained of heartburn and 94 (31.3%) experienced acid reflux more than once a week. The median RSI was 19.5 (range, 14-36) among 150 patients with GERD and LPR symptoms. When clinical characteristics were compared, patients with GERD and LPR symptoms were younger and a higher proportion had chronic lung disease than those without LPR.
Quality of life in patients with gastroesophageal reflux disease. Table 2 lists the proportions of patients who reported any problems (level 2 or 3) for each dimension of the EQ-5D questionnaire. GERD patients with LPR symptoms Quality of life in patients with GERD and LPR reported more problems in the pain/discomfort (58.7% vs 47.3%, P = 0.049) and anxiety/depression dimensions (39.3% vs 22.0%, P = 0.001) than those without LPR. The mean EQ-5D index was significantly lower in patients with LPR symptoms than in those without LPR (0.88 vs 0.91, P = 0.002) (Fig. 2) . Multiple regression analysis showed that the severity of LPR symptoms was related to HRQL when adjusted for age, gender, marital status, body mass index, household income, and comorbidity (Table 3) .
Patient satisfaction. In the study population, 120 patients (40.0%) received medical management and 58 (19.3%) received alternative medical management, including oriental medicine or herbal medicine (Table S1 ). The mean number of visits to the primary clinic for 6 months was similar between patients with GERD and those with GERD and LPR symptoms (1.27 AE 1.4 and 1.32 AE 1.8, P = 0.857). Satisfaction was evaluated in 130 patients whose treatment was provided in medical facilities, including 55 patients with GERD and 75 patients with GERD and LPR symptoms. GERD patients with LPR symptoms had lower overall satisfaction rates regarding treatment than those without LPR (40.0% vs 69.1%, P = 0.040) ( Table 4) . Satisfaction with the treating physician, including his or her level of concern, professional knowledge, and explanations, as well as satisfaction with medical costs and treatment outcomes, was significantly lower in patients with GERD and LPR symptoms.
Disease burden. Disease burden was assessed in 103 patients with GERD and 100 patients with GERD and LPR symptoms who were employed at that time ( Table 5 ). The work hours per week were similar between two groups: 47.8 h in patients with GERD and 45.5 h for patients with GERD and LPR symptoms (P = 0.516). The mean time absent from work in the previous 7 days due to symptoms was significantly longer (0.36 vs 0.02 h, P = 0.016), and work productivity was reduced (30.8% vs Quality of life in patients with GERD and LPR EJ Gong et al.
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.8%, P = 0.001) in patients with GERD and LPR symptoms compared with those without LPR. In the final outcome, the percentage of overall work impairment was greater in patients with GERD and LPR (31.1% vs 20.8%, P < 0.001).
Discussion
Gastroesophageal reflux disease is a major clinical problem with a negative impact on quality of life. Higher symptom burden has been associated with significant reductions in HRQL, and patients with persistent symptoms or recurrence are reported to have a worsened HRQL. [4] [5] [6] 18, 19 LPR is an extraesophageal manifestation of GERD causing variable symptoms that may affect daily activity. To date, however, the impact of LPR symptoms on HRQL in patients with GERD has not been studied. In our present study, we compared HRQL, patient satisfaction, and disease burden in GERD patients with and without LPR symptoms. The mean EQ-5D index was significantly lower in patients with GERD and LPR symptoms than in those without LPR. In addition, a linear regression model showed that the severity of LPR symptoms was related to a decreased HRQL. The overall satisfaction rate regarding treatment was lower, and the disease burden was greater in patients with GERD and LPR symptoms.
Laryngopharyngeal reflux is a chronic, relapsing condition that results from repeated exposure to refluxed gastric contents. The mechanisms thought to be responsible for LPR are the direct noxious effects of gastric juice on the mucosal surface of the pharynx or larynx, or the activation of reflexes involving the airways by the reflux of gastric contents into the esophagus. 20 LPR causes a variety of symptoms, including a globus sensation, hoarseness, throat clearing, and chronic cough, which are distinct from GERD. 8, 9 Patients with LPR often have multiple symptoms, and the HRQL of patients with LPR has previously been reported to be substantially lower than that of the general population. 9 In our current study, patients with GERD and LPR symptoms showed significantly lower values on the EQ-5D index than those without LPR, reporting more problems in the pain/discomfort and the anxiety/depression dimensions. This suggests that troublesome LPR symptoms have a significant negative impact on some aspects of patient quality of life in GERD patients.
Treatments for GERD and LPR rely on acid suppression therapy. 21, 22 GERD and LPR are related but distinct conditions with different symptoms and responses to therapy. The response to acid suppression therapy is the major difference between LPR and GERD. Treatment with a proton pump inhibitor is generally effective for the control of GERD symptoms. In contrast, it is thought that LPR symptoms require more aggressive and prolonged treatment than GERD. 11 Moreover, esophageal symptoms may rapidly improve after the initiation of proton pump inhibitor therapy, whereas the resolution of LPR symptoms is variable and sometimes takes several months. 10, 11 Although the factors underlying this significant difference in treatment response are not known, they can be partly explained by an earlier report showing that laryngeal mucosa is much more susceptible to acid-related injury. 23, 24 Because the airways are not protected by antireflux clearance mechanisms and intrinsic mucosal properties, even a single reflux episode may be sufficient to cause LPR symptoms. 20 These features in the clinical course may be attributable to the negative impact of LPR symptoms on HRQL and patient satisfaction in GERD patients. Indeed, in our present analysis, severe LPR symptoms were found to be associated with a poorer HRQL, and the overall satisfaction rate regarding the treatment was lower in patients with LPR symptoms. A structural approach and tailored management according to the presence of LPR symptoms should therefore be considered in patients with GERD to optimize treatment outcomes.
Several previous studies have shown that GERD has a significant impact on the socioeconomic burden of the patient in terms of work productivity. 4, 5, 19, 25 In addition to esophageal symptoms, the presence of LPR symptoms may also lead to reduced productivity. In our present study, GERD patients with LPR reported longer sickness-related absences and greater overall work impairment than those without LPR. In addition, GERD patients with LPR symptoms reported more problems in the pain/discomfort and anxiety/depression dimensions of the EQ-5D questionnaire, which may be related to social activities or healthcare-seeking behavior. The consideration of these results and the general assessment of patients, including symptom burden and sense of well-being would be beneficial in lessening this impact on work productivity.
Our study had several limitations of note. First, a selection bias could not be excluded, because our study population comprised patients residing in first-level cities. Second, as our initial screening survey was conducted using email, the possibility of a non-response bias must be considered. However, the overall contact and response rates were 23.6% and 56.7%, respectively, and the response rate was within an acceptable range in the email survey. 26 In addition, once selected, face-to-face interviews were performed by a trained professional interviewer to avoid further bias. Third, GERD was diagnosed based on typical symptoms and no further restrictions were defined. Therefore, a certain proportion of the study patients may have had structural disease or an esophageal motility disorder. However, because this study was population-based utilizing a nationwide survey, it was difficult to collect reliable data for objective measurements such as endoscopic examination or esophageal manometry. Another possible limitation of our study was that the severity of reflux symptoms was not evaluated. However, it is important to note that our analysis was not designed to evaluate the impact of reflux symptoms on HRQL, and therefore, we defined GERD as at least weekly symptoms of heartburn and/or acid regurgitation, with no reference to symptom severity. Despite these limitations, our present report is the first population-based study to evaluate HRQL and disease burden in GERD patients with LPR symptoms using validated questionnaires.
In conclusion, GERD patients with LPR symptoms have a lower HRQL than those without LPR, and the severity of LPR is related to a decreased HRQL. GERD patients with LPR have lower satisfaction with physicians, medical costs, and treatment outcomes. LPR symptoms also account for a significant burden in terms of increased loss of work and decreased productivity in GERD patients. These results suggest that structural assessment and tailored treatment of LPR symptoms are required to ensure better HRQL in patients with GERD.
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